The LLNL Bioassay Laboratory recently purchased a Perkin-Elmer DRCe ICP-MS (DRCe) to replace the existing Perkin-Elmer Elan 6000 ICP-MS (Elan 6000) used for the analysis of 238 U in urine bioassay samples. In accordance with section 5.7.2 of DOE-STD-1112-98, "The Department of Energy Laboratory Accreditation Program for Radiobioassay", this document demonstrates that the DRCe is technically equivalent to the Elan 6000. This paper documents: 1) Minor changes made in the procedure to improve the sensitivity; 2) Detection limits for the Elan 6000 and the DRCe; 3) Determination of the measurement uncertainty for the DRCe; and 4) Comparison of results from the DRCe versus the Elan 6000.
Technical Equivalence Between Perkin-Elmer DRCe and Elan 6000 for the Analysis of 238 U in Urine Bioassay Samples
The LLNL Bioassay Laboratory recently purchased a Perkin-Elmer DRCe ICP-MS (DRCe) to replace the existing Perkin-Elmer Elan 6000 ICP-MS (Elan 6000) used for the analysis of 238 U in urine bioassay samples. In accordance with section 5.7.2 of DOE-STD-1112-98, "The Department of Energy Laboratory Accreditation Program for Radiobioassay", this document demonstrates that the DRCe is technically equivalent to the Elan 6000. This paper documents: 1) Minor changes made in the procedure to improve the sensitivity; 2) Detection limits for the Elan 6000 and the DRCe; 3) Determination of the measurement uncertainty for the DRCe; and 4) Comparison of results from the DRCe versus the Elan 6000.
Summary of Existing Procedure
A 1 mL aliquot of the sample is transferred to an auto sampler tube. Nitric acid and 233 U (used as an internal standard) are added to the samples and the samples are digested in a microwave oven. The digested samples are diluted to 10 mL with deionized water and the 238 U concentration is determined by ICP-MS.
The ICP-MS is calibrated with a series of 238 U standards.
233
U is used as an internal standard to correct for suppression of the signal due to the sample matrix. The Elan 6000 is run in the peakhopping mode with 100 ms dwell times and 50 sweeps. The total integration time is 5,000 ms. The average of two measurements is used for the determination.
Modifications to the Procedure to Improve the Sensitivity
In order to reduce the interference from the presence of low levels of 238 U and 235 U in the 233 U internal standard, the amount of internal standard used was reduced from 50 uL to 10 uL. No other changes were made in the sample preparation steps.
The existing procedure included calibration standards at 0.005 ug/L to 0.1 ug/L. In the revised procedure, additional standards at 0.0005 ug/L and 0.001 ug/L were added to accommodate lower detection limits. Standards at 0.2 ug/L and 0.5 ug/L were also added to increase the dynamic range for the analysis.
The DRCe is run in the peak-hopping mode with 100 ms dwell times and 100 sweeps. The total integration time is 10,000 ms. The average result for three measurements is used for the determination of the final result. These modifications were made to improve the statistics for the analysis.
The two instruments are from the same manufacturer and run similar versions of the PerkinElmer Elan software (version 3.3 on the DRCe and 3.0 on the Elan 6000). No changes (other than those indicated above) to the operation of the instrument were required.
Modifications to the data transfer process from the DRCe to the LLNL Bioassay Laboratory Information Management System (BLIMS) database were made so that instrument data is transferred using the local laboratory network rather than using a floppy disk for the data transfer. Modifications were also made in the report to accommodate inclusion of the BLAB identification numbers on the ICP-MS reports.
Experimental
Blank urine (collected from individuals not occupationally exposed to uranium) were spiked with varying amounts of 238 U standard and analyzed as samples using the "Determination of Uranium in Urine by ICP/MS" procedure. Eight replicates at each concentration were prepared separately by four Bioassay Laboratory Analysts (two replicates per Analyst). Each series of spikes were run as separate runs on the DRCe. Results for the urine blanks were used to determine the detection limit. Results for the urine blanks and the spikes were used to determine the measurement uncertainty.
The results for these analyses are summarized in Table 1 . The seventh result for the 0.010 ug/L spike was determined to be an outlier (see Appendix A) and not used in any of the calculations. The high bias in the analytical results is due to the presence of natural uranium in the urine used to prepare the spikes.
Method Detection Limit (MDL 99 ) for the Elan 6000

"Method Development of Uranium Analysis in Urine Matrix by ICP-MS" describes the technical basis for the analysis of
238 U by ICP-MS on the Elan 6000. Included in this document is the determination of the Method Detection Limit (MDL) and the Reporting Limit (RL). The MDL 99 , is the minimum concentration of an analyte that in a given matrix can be measured and reported with 99% confidence that the analyte concentration is greater than zero. This value is equivalent to the Currie L C at the 99% confidence interval. Based on the analysis of ten replicate urine blank samples, the MDL 99 was determined to be 0.002 ug/L. A Reporting Limit (RL) of 0.01 ug/L, was derived by multiplying the MDL 99 by five.
Method Detection Limit (MDL 99 ) for the DRCe
For comparison purposes, the detection limit study described above was repeated on the DRCe. The procedure described in the experimental section of this document, which accounts for interanalyst and inter-run variability, was used for the determination. The original determination performed on the Elan 6000 was determined based on seven replicates prepared by a single analyst and analyzed in a single run. We feel that allowing for inter-analyst and inter-run variability provides a more realistic determination of the detection limit.
The MDL 99 is calculated as follows:
Where: t (n-1,0.99) = Student's t factor at the 99% confidence limit for n replicate values, and S = the standard deviation of the n replicate values 
Where: t (n-1,0.95) = Student's t factor at the 95% confidence limit for n replicate values, and S = the standard deviation of the n replicate values Note the Student's t factor is used because only a limited number of replicates were performed for the determination. For large numbers of replicates (well-known background) (2)( t (n-1,0.95) ) approaches 3.29.
Based on a standard deviation for the eight replicate samples of 0.0011 ug/L and a Student's t factor of 1.895, the MDA 95 is calculated to be 0.0042 ug/L.
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The L C95 is calculated as follows:
Where t (n-1,0.95) and S are defined as above.
Again the Student's t factor is used because only a limited number of replicates were performed for the determination. For large numbers of replicates (well-known background) t (n-1,0.95) approaches 1.645.
Based on a standard deviation for the eight replicate samples of 0.0011 ug/L and a Student's t factor of 1.895, the L C95 is calculated to be 0.0021 ug/L.
Required Measurement Quality Objectives (per Internal Dosimetry Requirements)
The 
Determination of the Measurement Uncertainty for the DRCe
The combined standard uncertainty (CSU, 1σ) of the analysis is estimated by the standard deviation of the replicate analyses. Based on the data included in Table 1 
Comparison of Results Between the DRCe and the Elan 6000
Three batches of samples containing from 35 to 55 samples were analyzed on both the Elan 6000 and the DRCe. Plots of the data comparing the results for the Elan 6000 versus the DRCe are included in Figure 2 through Figure 4 . The excellent correlation coefficients (R 2 > 0.9979) and slopes of approximately 1 (0.9893 to 1.0076) demonstrate that the results for the two instruments are equivalent.
Additional comparisons were performed using performance testing samples previously received from ORNL. Results for these comparisons are summarized in Table 2 . A two-tailed paired ttest, at the 95% confidence level, analysis of each of the two sets of data give P values of 0.547 and 0.329 indicating that the results are equivalent.
Summary
The information presented in this document clearly demonstrates that the new DRCe meets the MQO requirement for the LLNL Internal Dosimetry Program and that analytical results for the new instrument (DRCe) are technically equivalent to the old instrument (Elan 6000). The Lc and MDA 95 determined for this procedure of 0.0021 ug/L and 0.0042 ug/L are well below the expected detection limit of 0.01 ug/L. Additionally comparisons of the analyses of routine samples and performance testing samples on both the DRCe and the Elan 6000 demonstrate excellent agreement between the two instruments. 
